We move from a suspension to dry capsules.

Collaboration agreement signed with MedicorentInt. AB.

New partners with Pharma competence join us.

Approval of patent for treatment of allergic disorders.

Submission of patent application for the treatment of allergic disorders.

Sapienza conducts studies showing that Milmedhas zero toxicity.

Allergy study showed very clear indications of a positive effect against allergic disorders.

Funding of ongoing operations, new partners come in and Milmed Unico AB buys all intellectual property rights from the"old Milmed AB”.

Research agreement signed with Sapienza University in Rome, Europe's largest university.

Studies that all show a faster recovery and increased number of immune markers in the blood.

Research starts to go from a suspension to dry form, capsules.

First patent approved, patent protection in 11 countries.

Filing of patent application for treatment of neurodegenerative diseases.

Several studies with mice show reconstruction of the neurodegenerative systems of Parkinson’s disease mice.

The whole operation is moved to Sweden.

Many studies are conducted to prove what the effects of millimeter waves have on living cells.

Professor MB Golant discover the effect of millimeter waves have on biological objects.